Aperio Group’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-13,226
| Closed | -$94K | – | 2272 |
|
|
2017
Q3 | $94K | Buy |
13,226
+382
| +3% | +$2.72K | ﹤0.01% | 2188 |
|
|
2017
Q2 | $93K | Buy |
12,844
+472
| +4% | +$3.42K | ﹤0.01% | 2185 |
|
|
2017
Q1 | $76K | Buy |
12,372
+1,010
| +9% | +$6.2K | ﹤0.01% | 2121 |
|
|
2016
Q4 | $67K | Buy |
11,362
+403
| +4% | +$2.38K | ﹤0.01% | 2098 |
|
|
2016
Q3 | $58K | Buy |
+10,959
| New | +$58K | ﹤0.01% | 2038 |
|
|
2015
Q4 | – | Sell |
-10,664
| Closed | -$38K | – | 2042 |
|
|
2015
Q3 | $38K | Buy |
+10,664
| New | +$38K | ﹤0.01% | 1914 |
|
|
2015
Q2 | – | Sell |
-10,539
| Closed | -$134K | – | 2054 |
|
|
2015
Q1 | $134K | Sell |
10,539
-5,535
| -34% | -$70.4K | ﹤0.01% | 1890 |
|
|
2014
Q4 | $227K | Buy |
16,074
+1,878
| +13% | +$26.5K | ﹤0.01% | 1670 |
|
|
2014
Q3 | $195K | Buy |
14,196
+1,071
| +8% | +$14.7K | ﹤0.01% | 1611 |
|
|
2014
Q2 | $202K | Buy |
+13,125
| New | +$202K | ﹤0.01% | 1615 |
|